title: The Cost-Effectiveness of Exenatide Bid Versus Insulin Lispro Tid As Add-On Therapy to Titrated Insulin Glargine in Patients With Type 2 Diabetes - An Analysis From The Swedish Health Care Perspective.
authors.affiliation: Health Economics and Outcomes Research Ltd, Cardiff, UK.
authors.forename: J
authors.initials: J
authors.lastname: Gordon
authors.affiliation: Health Economics and Outcomes Research Ltd, Cardiff, UK.
authors.forename: P
authors.initials: P
authors.lastname: McEwan
authors.affiliation: AstraZeneca Nordic-Baltic, Södertälje, Sweden.
authors.forename: U
authors.initials: U
authors.lastname: Sabale
authors.affiliation: AstraZeneca Nordic-Baltic, Södertälje, Sweden.
authors.forename: B
authors.initials: B
authors.lastname: Kartman